tiprankstipranks
ANI Pharmaceuticals Inc (ANIP)
NASDAQ:ANIP
US Market

ANI Pharmaceuticals (ANIP) Income Statement

Compare
292 Followers

ANI Pharmaceuticals Income Statement

Last quarter (Q3 2024), ANI Pharmaceuticals's total revenue was $148.33M, an increase of 12.52% from the same quarter last year. In Q3, ANI Pharmaceuticals's net income was $-24.17M. See ANI Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 486.82M$ 316.38M$ 216.14M$ 208.47M$ 206.55M
Gross Profit
$ 305.30M$ 177.60M$ 115.53M$ 121.32M$ 143.39M
Operating Expenses
$ 258.33M$ 203.33M$ 143.69M$ 136.89M$ 126.97M
Depreciation and Amortization
$ 59.79M$ 56.97M$ 47.25M$ 44.64M$ 44.61M
EBITDA
$ 106.60M$ 48.07M$ -1.68M$ 29.07M$ 60.73M
Operating Income
$ 46.97M$ -25.06M$ -32.51M$ -16.06M$ 16.35M
Other Income/Expenses
$ -27.10M$ -27.38M$ -16.27M$ -9.95M$ -13.19M
Pretax Income
$ 19.87M$ -62.66M$ -56.06M$ -25.96M$ 3.16M
Net Income
$ 18.78M$ -47.90M$ -42.60M$ -22.55M$ 6.09M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 0.95$ -2.95$ -3.38$ -1.88$ 0.51
Diluted EPS
$ 0.94$ -2.95$ -3.38$ -1.88$ 0.50
Weighted Average Shares Outstanding
18.00M 16.26M 12.60M 11.96M 11.84M
Weighted Average Shares Outstanding (Diluted)
18.19M 16.26M 12.60M 11.96M 12.04M
Currency in USD

ANI Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis